KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Prepaid Assets (2016 - 2025)

Abbott Laboratories' Prepaid Assets history spans 17 years, with the latest figure at $2.6 billion for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 2.72% year-over-year to $2.6 billion; the TTM value through Dec 2025 reached $2.6 billion, up 2.72%, while the annual FY2025 figure was $2.6 billion, 2.72% up from the prior year.
  • Prepaid Assets for Q4 2025 was $2.6 billion at Abbott Laboratories, up from $2.3 billion in the prior quarter.
  • Across five years, Prepaid Assets topped out at $2.8 billion in Q3 2022 and bottomed at $2.0 billion in Q1 2021.
  • The 5-year median for Prepaid Assets is $2.3 billion (2023), against an average of $2.3 billion.
  • The largest annual shift saw Prepaid Assets soared 31.02% in 2022 before it dropped 15.28% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $2.3 billion in 2021, then rose by 13.51% to $2.7 billion in 2022, then decreased by 15.28% to $2.3 billion in 2023, then rose by 13.92% to $2.6 billion in 2024, then rose by 2.72% to $2.6 billion in 2025.
  • Per Business Quant, the three most recent readings for ABT's Prepaid Assets are $2.6 billion (Q4 2025), $2.3 billion (Q3 2025), and $2.3 billion (Q2 2025).